Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis

被引:0
|
作者
Dekeyser, Catherine [1 ]
De Kesel, Pieter [2 ]
Cambron, Melissa [3 ,4 ]
Vanopdenbosch, Ludo [3 ]
Van Hijfte, Liesbeth [1 ]
Vercammen, Martine [5 ,6 ]
Laureys, Guy [1 ]
机构
[1] Ghent Univ Hosp, Dept Neurol, Ghent, Belgium
[2] Ghent Univ Hosp, Dept Lab Med, Ghent, Belgium
[3] Dept Neurol, AZ Sint Jan Brugge, Brugge, Belgium
[4] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium
[5] Algemeen Ziekenhuis AZ Sint Jan Brugge, Dept Lab Med, Brugge, Belgium
[6] Vrije Univ Brussel, Basic Biomed Sci, Brussels, Belgium
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
multiple sclerosis; kappa free light chains; kappa FLC index; kappa IgG index; CSF kappa FLC/IgG ratio; Freelite (R)-Optilite versus N Latex (R)-BNII; BIOLOGICAL VARIATION; PERFORMANCE; BIOMARKER;
D O I
10.3389/fimmu.2024.1385231
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Cerebrospinal fluid (CSF) kappa free light chain (kappa FLC) measures gained increasing interest as diagnostic markers in multiple sclerosis (MS). However, the lack of studies comparing assay-dependent diagnostic cutoff values hinders their use in clinical practice. Additionally, the optimal kappa FLC parameter for identifying MS remains a subject of ongoing debate. Objectives: The aim of this study was to compare same-sample diagnostic accuracies of the kappa FLC index, kappa IgG index, CSF kappa FLC/IgG ratio, and isolated CSF kappa FLC (iCSF-kappa FLC) between two reference centers using different methods. Methods: Paired serum and CSF samples were analyzed for kappa FLC and albumin concentrations by Freelite (R)-Optilite (Sint-Jan Bruges hospital) and N Latex (R)-BNII (Ghent University hospital). Diagnostic performance to differentiate MS from controls was assessed using ROC curve analysis. Results: A total of 263 participants were included (MS, n = 80). Optimal diagnostic cutoff values for the kappa FLC index (Freelite (R)-Optilite: 7.7; N Latex (R)-BNII: 4.71), kappa IgG index (Freelite (R)-Optilite: 14.15, N Latex (R)-BNII: 12.19), and CSF kappa FLC/IgG ratio (Freelite (R)-Optilite: 2.27; N Latex (R)-BNII: 1.44) differed between the two methods. Sensitivities related to optimal cutoff values were 89.9% (Freelite (R)-Optilite) versus 94.6% (N Latex (R)-BNII) for the kappa FLC index, 91% (Freelite (R)-Optilite) versus 92.2% (N Latex (R)-BNII) for the kappa IgG index, and 81.3% (Freelite (R)-Optilite) versus 91.4% (N Latex (R)-BNII) for the CSF kappa FLC/IgG ratio. However, for iCSF-kappa FLC, optimal diagnostic cutoff values (0.36 mg/L) and related specificities (81.8%) were identical with a related diagnostic sensitivity of 89.9% for Freelite (R)-Optilite and 90.5% for N Latex (R)-BNII. The diagnostic performance of the kappa FLC index [area under the curve (AUC) Freelite (R)-Optilite: 0.924; N Latex (R)-BNII: 0.962] and kappa IgG index (AUC Freelite (R)-Optilite: 0.929; N Latex (R)-BNII: 0.961) was superior compared to CSF oligoclonal bands (AUC: 0.898, sensitivity: 83.8%, specificity: 95.9%). Conclusions: The kappa FLC index and the kappa IgG index seem to be excellent markers for identifying MS, irrespective of the method used for kappa FLC quantification. Based on the AUC, they appear to be the measures of choice. For all measures, optimal cutoff values differed between methods except for iCSF-kappa FLC. iCSF-kappa FLC might therefore serve as a method-independent, more cost-efficient, initial screening measure for MS. These findings are particularly relevant for clinical practice given the potential future implementation of intrathecal kappa FLC synthesis in MS diagnostic criteria and for future multicentre studies pooling data on kappa FLC measures.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis
    Gaetani, Lorenzo
    Di Carlo, Marinella
    Brachelente, Giovanni
    Valletta, Federico
    Eusebi, Paolo
    Mancini, Andrea
    Gentili, Lucia
    Borrelli, Angela
    Calabresi, Paolo
    Sarchielli, Paola
    Ferri, Carla
    Villa, Alfredo
    Di Filippo, Massimiliano
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 339
  • [32] IMMUNOGLOBULIN FREE LIGHT-CHAINS IN MULTIPLE-SCLEROSIS CEREBROSPINAL-FLUID
    GALLO, P
    SIDEN, A
    TAVOLATO, B
    RECENT ADVANCES IN MULTIPLE SCLEROSIS THERAPY, 1989, 863 : 341 - 343
  • [33] Cerebrospinal fluid kappa free light chains in patients with tumefactive demyelination
    Banks, Samantha A.
    Willrich, Maria Alice V.
    Eckel-Passow, Jeanette E.
    Tobin, W. Oliver
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024, 62 (08) : e189 - e192
  • [34] The Role of Assay of Free Immunoglobulin Light Chains in the Diagnosis of the Onset of Multiple Sclerosis
    Nazarov V.D.
    Makshakov G.S.
    Mazing A.V.
    Surkova E.A.
    Krasnov V.S.
    Shumilina M.V.
    Totolyan N.A.
    Evdoshenko E.P.
    Lapin S.V.
    Emanuel’ V.L.
    Skoromets A.A.
    Neuroscience and Behavioral Physiology, 2018, 48 (6) : 680 - 685
  • [35] The contribution of the free light chain test in cerebrospinal fluid in the diagnosis of multiple sclerosis
    Calcagno, L.
    Montarolo, C.
    Erli, F.
    Piacentini, A.
    Repetto, V.
    Enriotti, C.
    Ciriello, M. M.
    CLINICA CHIMICA ACTA, 2024, 558 : 86 - 87
  • [36] Intrathecal kappa free light chains as markers for multiple sclerosis
    Vecchio, D.
    Bellomo, G.
    Serino, R.
    Virgilio, E.
    Lamonaca, M.
    Dianzani, U.
    Cantello, R.
    Comi, C.
    Crespi, I
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [37] The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
    Arneth, Borros
    Kraus, Joerg
    MEDICINA-LITHUANIA, 2022, 58 (11):
  • [38] Intrathecal kappa free light chains as markers for multiple sclerosis
    D. Vecchio
    G. Bellomo
    R. Serino
    E. Virgilio
    M. Lamonaca
    U. Dianzani
    R. Cantello
    C. Comi
    I. Crespi
    Scientific Reports, 10
  • [39] The diagnostic utility of kappa free light chains in people with multiple sclerosis and other neuroinflammatory disorders
    Konen, F. F.
    Schwenkenbecher, P.
    Jendretzky, K. F.
    Gingele, S.
    Suehs, K. -W.
    Witte, T.
    Grothe, M.
    Tumani, H.
    Suesse, M.
    Skripuletz, T.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 315 - 316
  • [40] Cerebrospinal fluid free light chains as diagnostic biomarker in neuroborreliosis
    Hegen, Harald
    Milosavljevic, Dejan
    Schnabl, Christine
    Manowiecka, Andrea
    Walde, Janette
    Deisenhammer, Florian
    Presslauer, Stefan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (08) : 1383 - 1391